Raymond James & Associates’s WisdomTree Europe Quality Dividend Growth Fund EUDG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.42M Buy
246,951
+10,790
+5% +$357K 0.01% 1319
2024
Q2
$7.57M Buy
236,161
+47,384
+25% +$1.54M 0.01% 1330
2024
Q1
$6.17M Buy
188,777
+34,664
+22% +$1.11M ﹤0.01% 1441
2023
Q4
$4.91M Buy
154,113
+9,862
+7% +$292K ﹤0.01% 1546
2023
Q3
$4.12M Buy
144,251
+6,482
+5% +$195K ﹤0.01% 1589
2023
Q2
$4.22M Sell
137,769
-5,830
-4% -$179K ﹤0.01% 1600
2023
Q1
$4.33M Buy
143,599
+5,077
+4% +$147K ﹤0.01% 1556
2022
Q4
$3.78M Sell
138,522
-98,943
-42% -$2.57M ﹤0.01% 1607
2022
Q3
$5.48M Sell
237,465
-6,140
-3% -$159K 0.01% 1317
2022
Q2
$6.4M Buy
243,605
+94,022
+63% +$2.71M 0.01% 1239
2022
Q1
$4.68M Buy
+149,583
New +$4.8M ﹤0.01% 1560

Other funds holding EUDG

Raymond James & Associates's EUDG Position: Q3 2024 in Review

Raymond James & Associates increased its WisdomTree Europe Quality Dividend Growth Fund (EUDG) stake by 4.6% in Q3 2024, buying an estimated $357K and bringing the position to 246,951 shares worth $8.42M. The position accounts for 0.01% of the portfolio, ranked #1319.

Raymond James & Associates first reported a position in EUDG in Q1 2022 and has held it in 11 quarters since. 38 funds tracked by Wall St. Rank hold EUDG as of Q3 2024.

  • Raymond James & Associates held 246,951 shares of WisdomTree Europe Quality Dividend Growth Fund worth $8.42M as of Q3 2024.
  • Raymond James & Associates bought 10,790 WisdomTree Europe Quality Dividend Growth Fund shares in Q3 2024, an estimated $357K.
  • WisdomTree Europe Quality Dividend Growth Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1319 holding.
  • Raymond James & Associates first reported a position in WisdomTree Europe Quality Dividend Growth Fund in Q1 2022 and has held it in 11 quarters since.
  • 38 funds tracked by Wall St. Rank held WisdomTree Europe Quality Dividend Growth Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.